Reduced intensity versus full myeloablative stem cell transplant for advanced CLL

Area of Science:

• Hematology
• Oncology
• Stem Cell Transplantation

Background:

• Chronic lymphocytic leukemia (CLL) is generally incurable with standard treatments.
• Allogeneic hematopoietic stem cell transplant (HCT) presents a potential curative option for advanced CLL.
• This study evaluates HCT outcomes in advanced CLL patients.

Purpose of the Study:

• To compare the efficacy and safety of reduced-intensity conditioning (RIC) versus full-intensity conditioning (FIC) allogeneic HCT in advanced CLL.
• To assess overall survival (OS), transplant-related mortality (TRM), and relapse rates between RIC and FIC groups.
• To identify factors influencing outcomes in advanced CLL patients undergoing HCT.

Main Methods:

• Retrospective analysis of 50 advanced CLL patients undergoing allogeneic HCT between 1996-2006.
• Patients were divided into RIC (n=21) and FIC (n=29) groups.
• FIC regimens included cyclophosphamide (CY), etoposide, and BCNU, or busulfan (BU) and CY.

Main Results:

• RIC recipients were older (median 54 vs 51 years) and had more unrelated donors (62% vs 31%).
• Despite these factors, 5-year OS was significantly higher in the RIC group (63%) compared to FIC (18%).
• TRM was substantially lower in the RIC group (14% at day 100) versus FIC (27% at day 100).

Conclusions:

• Reduced-intensity conditioning (RIC) allogeneic HCT demonstrates a favorable outcome for advanced CLL patients compared to full-intensity conditioning (FIC).
• RIC significantly lowers transplant-related mortality, improving survival rates in this patient population.
• RIC should be considered a preferred conditioning regimen for advanced CLL patients undergoing allogeneic HCT.